Drugs@FDA: FDA-Approved Drugs
Biologic License Application (BLA): 103608
Company: CYTOGEN
Company: CYTOGEN
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
PROSTASCINT | CAPROMAB PENDETIDE | 05.MG/ML | VIAL; INTRAVENOUS | Prescription | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/28/1996 | ORIG-1 | Approval | N/A |
Label (PDF)
Letter Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/capcyt102896lab.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1996/capcyt102896L.htm https://web.archive.org/web/20170118085129/https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/TherapeuticBiologicApplications/ucm080734.htm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
06/26/2012 | SUPPL-5043 | Supplement |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103608s5043lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2012/103608s5043ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
06/26/2012 | SUPPL-5043 | Supplement | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/103608s5043lbl.pdf | |
10/28/1996 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/1996/capcyt102896lab.pdf |